These biotech stocks could shine next year.
If you're looking for Buffett stocks, it's a good time to consider U.S. Bancorp, Verizon Communications, and Mastercard.
There's one clear pace-setter, but there are other retailers who had a good year.
Price is what you pay (per share). Market capitalization is what you get.
These great stocks offer excellent yields, exceptional growth, and are terrific bargains.
The warehouse retailer saw same-store sales climb as expected.
President-elect Donald Trump took aim at drug developers in a recent Time magazine interview and as a result, biopharma stocks are selling off.
The company made a very risky move, and it paid off.
AstraZeneca's shares continued their downward spiral last month, falling by more than 8%.
Whether you’re looking for blazing growth or steadily increasing investment income, the healthcare sector is ready to meet your needs.